These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15067624)

  • 21. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
    Corinaldesi R; Stanghellini V; Raiti C; Rea E; Salgemini R; Barbara L
    Gut; 1987 Mar; 28(3):300-5. PubMed ID: 3552906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
    Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
    J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices.
    Verhaeghe J; Jaecques N; Rombouts J; Spaepen W; Cardon E; Lebrun F; Meurant JP
    Scand J Gastroenterol Suppl; 1993; 195():25-34; discussion 34-5. PubMed ID: 8516655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies.
    Kearney DJ; Avins AL; McQuaid KR
    Am J Gastroenterol; 2000 Sep; 95(9):2212-7. PubMed ID: 11007220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial.
    Yeoh KG; Kang JY; Tay HH; Gwee KA; Tan CC; Wee A; Teh M; Choo HF; Chintana-Wilde W
    J Gastroenterol Hepatol; 1997 Jan; 12(1):13-8. PubMed ID: 9076616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cisapride therapy in functional dyspepsia.
    Kellow JE; Cowan H; Shuter B; Riley JW; Lunzer MR; Eckstein RP; Höschl R; Lam SK
    Aliment Pharmacol Ther; 1995 Apr; 9(2):153-60. PubMed ID: 7605855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].
    Serra J
    Gastroenterol Hepatol; 2010 Oct; 33(8):586-90. PubMed ID: 20850200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A German drug-monitoring study in general practice patients receiving cisapride for functional dyspepsia.
    Liehr H; Schmidt R
    Scand J Gastroenterol Suppl; 1993; 195():54-8; discussion 58-9. PubMed ID: 8516660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
    Wood SF; Penney SC; Cochran KM
    Scand J Gastroenterol Suppl; 1993; 195():5-10. PubMed ID: 8516659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study.
    Holtmann G; Kutscher SU; Haag S; Langkafel M; Heuft G; Neufang-Hueber J; Goebell H; Senf W; Talley NJ
    Dig Dis Sci; 2004 Apr; 49(4):672-9. PubMed ID: 15185877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting short- and long-term outcome of a short therapeutic trial with cisapride in dyspeptic patients.
    Heyse PM; Rambaldo R; Hazelhoff B
    Scand J Gastroenterol Suppl; 1993; 195():15-23; discussion 23-4. PubMed ID: 8516654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.
    Rösch W
    Clin Ther; 1994; 16(3):437-45. PubMed ID: 7923310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study.
    de Groot GH; de Both PS
    Aliment Pharmacol Ther; 1997 Feb; 11(1):193-9. PubMed ID: 9042993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallbladder hypokinesia and normal gastric emptying of liquids in patients with dyspeptic symptoms. A double-blind placebo-controlled clinical trial with cisapride.
    Marzio L; DiFelice F; Laico MG; Imbimbo B; Lapenna D; Cuccurullo F
    Dig Dis Sci; 1992 Feb; 37(2):262-7. PubMed ID: 1735345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial.
    Fumagalli I; Hammer B
    Scand J Gastroenterol; 1994 Jan; 29(1):33-7. PubMed ID: 8128175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of cisapride in the treatment of epigastric pain and concomitant symptoms in non-ulcer dyspepsia.
    Rösch W
    Scand J Gastroenterol Suppl; 1989; 165():54-8. PubMed ID: 2690325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia.
    Holtmann G; Gschossmann J; Karaus M; Fischer T; Becker B; Mayr P; Gerken G
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1459-65. PubMed ID: 10571602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.